Repeat booster jabs for residents? COVID-19 immunity in nursing homes wanes quickly, large study shows
By
Alicia Lasek
Mar 21, 2022
Results from hundreds of facilities demonstrate not only the value of booster vaccinations, but that there may be an ongoing need for additional shots in the long-term care population.
Death toll rises as nursing home operator faces 7 closures, legal scrutiny over hurricane evacuation
By
Kimberly Marselas
Sep 07, 2021
Seven nursing home residents have now died after being shipped to a warehouse in advance of Hurricane Ida, and Louisiana officials have ordered the temporary closure of the seven nursing homes where they...
It’s official: Omicron causes less severe COVID-19 illness than prior variants, CDC study finds
By
Alicia Lasek
Jan 26, 2022
The SARS-CoV-2 omicron variant is much less likely to cause severe illness and death than its predecessors, according to a new analysis of U.S. data from December 2020 through mid-January 2022.
‘We want more tests, not less’: HHS doubles down on COVID antigen testing
By
Alicia Lasek
Oct 27, 2020
Testing is critical to keeping the coronavirus in check in long-term care facilities as U.S. case counts trend back upward, said Adm. Brett Giroir, M.D. Federal agencies continue to deliver antigen tests...
Use thermal disinfection for hygienically clean laundry
By
Paulo Rocha
Apr 08, 2021
It’s no surprise the COVID-19 pandemic has increased the demand for hygienic best practices around the globe. With senior citizens being one of the most at-risk populations, it is vital for long-term...
‘Out in the cold’: LTC pharmacies ask to be matched with vaccination sites, relief funds
By
Alicia Lasek
Dec 22, 2020
As their businesses groan under the weight of COVID-19-related expenses, long-term care pharmacists are pressing federal officials for relief funds and asking for a bigger role in coronavirus vaccinations.
Why invest in air purification for long-term care facilities?
By
Michelle Mendoza
Apr 15, 2021
COVID-19 vaccines will not completely eliminate the virus and make everything go back to normal right away. Instead, it is likely COVID-19 will be around for several years. Communities will have to live...
New ‘weapon in our arsenal’: Antibody drug cuts COVID risk by 80 percent in LTC residents
By
Alicia Lasek
Jan 22, 2021
Staff and residents who received Eli Lilly’s monoclonal antibody therapy were less likely to contract symptomatic COVID-19 than placebo groups in a late-stage trial. Industry advocates are hailing...
The killer hiding on the porch
By
Gary Tetz
May 19, 2022
I’m not easily surprised these days, because…everything. But I just stumbled across an astonishing bit of data.
Rollout of COVID antibody therapy requires clinician feedback, U.S. officials say
By
Alicia Lasek
Nov 11, 2020
Federal agencies say they will depend on clinician input during distribution of Eli Lilly’s new intravenous antibody therapy for high-risk COVID-19 patients.